Rates of control for first bleeding episodes by first-line therapy
Hemostatic agent . | First-line bleeding control . | |
---|---|---|
n . | % . | |
Unmatched samples | ||
Bypassing agent | 219 | 91.8 |
FVIIa | 159 | 91.2 |
aPCC | 60 | 93.3 |
Replacement therapy | 69 | 69.6 |
FVIII | 55 | 70.1 |
DDAVP | 14 | 64.3 |
PS-matched samples | ||
Bypassing agent | 60 | 93.3 |
Replacement therapy | 60 | 68.3 |
rFVIIa | 57 | 93.0 |
aPCC | 57 | 93.0 |
Hemostatic agent . | First-line bleeding control . | |
---|---|---|
n . | % . | |
Unmatched samples | ||
Bypassing agent | 219 | 91.8 |
FVIIa | 159 | 91.2 |
aPCC | 60 | 93.3 |
Replacement therapy | 69 | 69.6 |
FVIII | 55 | 70.1 |
DDAVP | 14 | 64.3 |
PS-matched samples | ||
Bypassing agent | 60 | 93.3 |
Replacement therapy | 60 | 68.3 |
rFVIIa | 57 | 93.0 |
aPCC | 57 | 93.0 |